Exploring the Role of Chinese Medicine in Cardiovascular Care
The 21st World Congress of Chinese Medicine (WCCM) initiated vital conversations regarding the integration of traditional practices in modern health care. This significant event took place at UNESCO Headquarters, emphasizing the potent contributions of Chinese medicine to global health, especially in treating cardiovascular and cerebrovascular diseases.
Key Highlights of the Congress
A central aspect of the congress was the seminar focused on the Integration of Industry and Education in Cardiovascular and Cerebrovascular Diseases. This event was hosted by the Industry-Education Integration Promotion Committee of the World Federation of Chinese Medicine Societies and organized by Jimon Group. Its aim was to showcase groundbreaking research and clinical applications of Chinese medicine, underlining its essential role in disease prevention and treatment.
Advancing Chinese Medicine Globally
Jimon Group played an essential role in this seminar, particularly through the launch of its Chinese Medicine for Global Health Industry Expansion Plan. The Chairman, Mr. Niu, highlighted their ambitious goal to expand the reach of Chinese medicine internationally and establish a center dedicated to integrating education and industry in Paris. This initiative intends to promote a global health community enriched with resources and expertise.
Collaboration and Partnerships
The seminar crowned a series of collaborations formalized through a signing ceremony. Jimon Group partnered with numerous prestigious entities to promote the integration of traditional and modern practices in healthcare. This collaboration expands their market reach while enhancing their product's competitiveness by leveraging local resources. Furthermore, these partnerships are crucial for advancing the recognition of Chinese medicine in healthcare practices worldwide.
Insightful Discussions and Exchanges
The roundtable dialogue session brought together leading practitioners and researchers who shared their insights on the evolution of Chinese medicine. They exchanged ideas on how to further cultural heritage while embracing innovations, setting the stage for enhanced international collaboration.
The Future of Chinese Medicine
Jimon Group's engagement in the WCCM showcased their commitment to the cultural and practical advancements in Chinese medicine on a global scale. With an unwavering mission to inherit the rich traditions of Chinese medicine while pushing for progressive research, Jimon Group is dedicated to making a significant impact in preventing and treating cardiovascular and cerebrovascular diseases worldwide.
In this rapidly evolving healthcare landscape, companies like Jimon Group are crucial in driving forward the integration of ancient wisdom with modern practices. Their vision aims to benefit countless individuals globally, paving the way for a healthier future.
Frequently Asked Questions
What is the purpose of the 21st World Congress of Chinese Medicine?
The congress aims to explore the integration of traditional Chinese medicine with modern healthcare practices, particularly in treating cardiovascular diseases.
Who were the key speakers at the seminar?
Notable attendees included Ramon Maria Calduch, Zhang Boli, and Niu Liwei, who discussed various aspects of Chinese medicine and its global expansion.
What initiatives were launched during the congress?
A significant initiative was the Chinese Medicine for Global Health Industry Expansion Plan, aimed at promoting the international reach of Chinese medicine.
Which organizations collaborated with Jimon Group?
Jimon Group collaborated with several institutions, including the Association des Ingénieurs Chinois, the International Chinese Medicine and Healthcare General Association, and others.
How does Jimon Group plan to enhance the global presence of Chinese medicine?
By establishing partnerships and dedicated centers, Jimon Group aims to leverage local resources to enhance recognition and understanding of Chinese medicine globally.
